Feb 02, 2022 / 03:00PM GMT
Karen Hunady - Athersys, Inc. - Director of Corporate Communications & IR
Hello, everyone. My name is Karen Hunady, and I'm the Director of Corporate Communications and Investor Relations here at Athersys. We are delighted to have this opportunity to communicate with our shareholders, and we thank you for joining us for our virtual presentation today, MultiStem clinical programs and in-depth look.
This event is expected to last about an hour, and we'll conclude with a question-and-answer session. You may submit a question at any time during the presentation by clicking on the bar below the video player that says Ask-a-Question. This presentation is being recorded, and the replay will be able on our website at athersys.com, shortly after the event.
I need to remind everyone that we will be making forward-looking statements and the safe harbor rules govern our remarks we make today. These statements are subject to a number of risks and uncertainties that could cause actual results to differ materially. These risks are detailed on this slide as well as in the Risk Factors section of our
Athersys Inc MultiStem Clinical Programs: An In-Depth Look Call Transcript
Feb 12, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers